Tag: Australian biotech firm
CSL to buy majority stake in a leading Chinese plasma fractionator
Australian biotech firm CSL has agreed to acquire an 80% stake in China’s plasma-derived therapies manufacturer Wuhan Zhong Yuan Rui De Biologics (Ruide) in...
Featured Article
Beyond insights: How CRM solutions are transforming the manufacturing industry
The global manufacturing sector is witnessing a seismic shift in its automation approach as companies worldwide, big or small, grapple with the ongoing labour shortage and skills gap within the industry.
